<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26810">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02757716</url>
  </required_header>
  <id_info>
    <org_study_id>FF 146/2015</org_study_id>
    <nct_id>NCT02757716</nct_id>
  </id_info>
  <brief_title>Addiction Remission and Addiction Transfer After Bariatric Surgery</brief_title>
  <official_title>Addiction Remission and Addiction Transfer After Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sana Klinikum Offenbach</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sana Klinikum Offenbach</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate addiction remission and addiction transfer after bariatric surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective study to evaluate addiction remission and addiction transfer 6, 12 and 24
      month after primary surgery (sleeve gastrectomy, Roux-en-Y- gastric bypass and Omega-Loop
      gastric bypass) in obese patients. A questionnaire evaluating food addiction (Yale Food
      Scale), alcohol addiction (Audit Scale), nicotine addiction (Fagerström Scale), sport
      addiction, internet addiction and drug addiction (Drug Use Questionnaire) gets completed
      prior to surgery and 6, 12 and 24 month after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Addiction remission</measure>
    <time_frame>12 month after surgery</time_frame>
    <description>Addiction remission (evaluated by questionnaire) after obesity surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Addiction transfer</measure>
    <time_frame>12 month after surgery</time_frame>
    <description>Addiction transfer (evaluated by questionnaire) after obesity surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Excess Weight Loss (EWL in %)</measure>
    <time_frame>12 month after surgery</time_frame>
    <description>EWL 12 month after surgery measured as a physiological parameter at 1 year Follow-Up</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Sleeve Gastrectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Obese patients who undergo sleeve gastrectomy fill in questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Roux-en-Y-Gastric Bypass</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Obese patients who undergo roux-en-y-gastric bypass fill in questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omega-Loop-Gastric Bypass</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Obese patients who undergo omega-loop gastric bypass fill in questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Every patient who undergo surgery will fill out a questionnaire containing validated scales concerning food, alcohol, nicotine, internet and sport addiction prior and 6, 12 and 24 month after surgery.</description>
    <arm_group_label>Sleeve Gastrectomy</arm_group_label>
    <arm_group_label>Roux-en-Y-Gastric Bypass</arm_group_label>
    <arm_group_label>Omega-Loop-Gastric Bypass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 35kg/m² and obesity related disease or BMI &gt; 40kg/m²

        Exclusion Criteria:

          -  decline of study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rudolf Weiner, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Sana Klinikum Offenbach, Department of Obesity and Metabolic Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sonja Chiappetta, MD</last_name>
    <phone>0049 69 8405 1706</phone>
    <email>sonja.chiappetta@sana.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Stier, MD</last_name>
    <phone>0049 69 8405 1733</phone>
    <email>christine.stier@sana.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sana Klinikum Offenbach</name>
      <address>
        <city>Offenbach</city>
        <state>Offenbach am Main</state>
        <zip>63069</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonja Chiappetta, MD</last_name>
      <phone>0049 69 8405 1706</phone>
      <email>sonja.chiappetta@sana.de</email>
    </contact>
    <contact_backup>
      <last_name>Christine Stier, MD</last_name>
      <phone>0049 69 8405 1733</phone>
      <email>christine.stier@sana.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Volkow ND, Wang GJ, Tomasi D, Baler RD. The addictive dimensionality of obesity. Biol Psychiatry. 2013 May 1;73(9):811-8. doi: 10.1016/j.biopsych.2012.12.020. Epub 2013 Jan 29. Review.</citation>
    <PMID>23374642</PMID>
  </results_reference>
  <results_reference>
    <citation>Pepino MY, Stein RI, Eagon JC, Klein S. Bariatric surgery-induced weight loss causes remission of food addiction in extreme obesity. Obesity (Silver Spring). 2014 Aug;22(8):1792-8. doi: 10.1002/oby.20797. Epub 2014 May 23.</citation>
    <PMID>24852693</PMID>
  </results_reference>
  <results_reference>
    <citation>Cuellar-Barboza AB, Frye MA, Grothe K, Prieto ML, Schneekloth TD, Loukianova LL, Hall-Flavin DK, Clark MM, Karpyak VM, Miller JD, Abulseoud OA. Change in consumption patterns for treatment-seeking patients with alcohol use disorder post-bariatric surgery. J Psychosom Res. 2015 Mar;78(3):199-204. doi: 10.1016/j.jpsychores.2014.06.019. Epub 2014 Sep 7.</citation>
    <PMID>25258356</PMID>
  </results_reference>
  <results_reference>
    <citation>Fowler L, Ivezaj V, Saules KK. Problematic intake of high-sugar/low-fat and high glycemic index foods by bariatric patients is associated with development of post-surgical new onset substance use disorders. Eat Behav. 2014 Aug;15(3):505-8. doi: 10.1016/j.eatbeh.2014.06.009. Epub 2014 Jun 20.</citation>
    <PMID>25064307</PMID>
  </results_reference>
  <results_reference>
    <citation>Ivezaj V, Saules KK, Wiedemann AA. &quot;I didn't see this coming.&quot;: why are postbariatric patients in substance abuse treatment? Patients' perceptions of etiology and future recommendations. Obes Surg. 2012 Aug;22(8):1308-14. doi: 10.1007/s11695-012-0668-2.</citation>
    <PMID>22661046</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 29, 2016</lastchanged_date>
  <firstreceived_date>April 21, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sana Klinikum Offenbach</investigator_affiliation>
    <investigator_full_name>Christine Stier</investigator_full_name>
    <investigator_title>Dr. med. Sonja Chiappetta, Dr. med. Christine Stier</investigator_title>
  </responsible_party>
  <keyword>addiction remission</keyword>
  <keyword>addiction transfer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
